Compare PCRX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | EXPI |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2010 | 2010 |
| Metric | PCRX | EXPI |
|---|---|---|
| Price | $22.83 | $6.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $35.33 | $11.50 |
| AVG Volume (30 Days) | 736.7K | ★ 985.6K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $541,533,000.00 | $500,147,681.00 |
| Revenue This Year | $9.77 | $6.93 |
| Revenue Next Year | $9.71 | $5.37 |
| P/E Ratio | $140.38 | ★ N/A |
| Revenue Growth | 26.04 | ★ 220.39 |
| 52 Week Low | $18.80 | $6.01 |
| 52 Week High | $27.99 | $12.23 |
| Indicator | PCRX | EXPI |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 16.13 |
| Support Level | $20.41 | N/A |
| Resistance Level | $23.82 | $11.36 |
| Average True Range (ATR) | 1.01 | 0.30 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 68.81 | 5.64 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.